
EMA Regulatory Dossier Strategist
Build EMA-compliant regulatory dossiers with structured workflows and checkpoints
What You Can Do
Navigate the complex EMA/ICH submission process by generating structured Common Technical Document (CTD) frameworks, compliance checklists, and quality assessment strategies. You'll accelerate dossier preparation, reduce submission delays, and ensure all regulatory requirements are systematically addressed before filing.
Features
Pre-structured Common Technical Document templates for all five modules (Admin, Summaries, Quality, Nonclinical, Clinical) aligned with current ICH Q14/Q3C guidelines
Systematic validation workflows that verify each module meets EMA requirements, flags missing sections, and identifies common deficiencies before submission
Evidence-based frameworks for module 3 preparation including CMC risk assessment, drug substance/product characterization, and manufacturing process optimization
Decision trees for selecting appropriate regulatory pathways (standard, accelerated, conditional, or priority review) based on therapeutic indication and unmet medical need
Proactive identification of high-risk sections and pre-drafted mitigation language to address anticipated regulatory questions and deficiency letters
Guidance for tailoring dossier content for simultaneous EMA/MHRA/ICH pathways, including region-specific documentation requirements and submission format variations
Gantt-style development schedules and workload allocation frameworks to coordinate across Quality, Nonclinical, and Clinical teams for on-time delivery
Example Output
Example 1: Module 3 Compliance Checklist
- ✅ Drug Substance: Characterization (structure, polymorphs, salts, impurities)
- ✅ Drug Product: Composition, formulation development, manufacturing process
- ⚠️ Stability Data: Incomplete long-term data for secondary packaging
- ❌ Container Closure Integrity: Testing protocol missing
Example 2: Quality Overall Summary (Module 2.3) Framework Generated 8-section structure covering synthesis route, characterization, specifications, analytical methods, stability protocols, manufacturing controls, and risk assessments with cross-references to supporting data sections.
Example 3: Submission Risk Matrix Ranked risk factors (High/Medium/Low) with pre-drafted mitigation language for: excipient sourcing variability, batch-to-batch consistency, shelf-life extrapolation, and manufacturing scale-up impact.
What's Included
- SKILL.md Regulatory Workflows: Complete regulatory strategies with decision trees, compliance frameworks, and structured checklists for navigating EMA/ICH pathways from protocol to filing
- CTD Template Library: Fillable templates for all five CTD modules with section-by-section guidance, required elements, and EMA-compliant formatting examples
- Compliance Validation Checklist: Module-level verification framework covering Module 1 (Admin), Module 2 (Summaries), Module 3 (Quality), Module 4 (Nonclinical), and Module 5 (Clinical)
- Quality Assessment Frameworks: Risk-based approaches for characterization, specifications, analytical methods, stability testing, and manufacturing process control aligned with ICH Q3C and Q14
- Regulatory Strategy Toolkit: Pathway selection criteria, accelerated/priority review triggers, conditional approval guidance, and post-approval compliance planning tools
Who It's For
- Regulatory Affairs Managers
- Quality Assurance Directors
- Clinical Development Project Leads
- Pharmaceutical Consultants
- Medical Device Regulatory Specialists
Best For
- Marketing Authorization Applications (MAA) for new drugs
- Common Technical Document (CTD) assembly and optimization
- EMA/MHRA submission preparation and strategy
- Post-approval compliance and variation management
- Quality Overall Summary (Module 2.3) development





